Cambria Pharmaceuticals, Inc.

United States of America

Create a watch for Cambria Pharmaceuticals, Inc.
Total IP 4
Total IP Rank # 390,858
IP Activity Score 0/5.0    0
IP Activity Rank # 1,709,712

Patents

Trademarks

0 0
0 0
4 0
0
 
Last Patent 2012 - Butaclamol for the treatment of ...
First Patent 1999 - Insect control agent

Latest Inventions, Goods, Services

2010 Invention Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis. The present inv...
Invention Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis. The present i...
Invention Butaclamol for the treatment of amyotrophic lateral sclerosis. The present invention relates to ...
Invention Butaclamol for the treatment of amyotrophic lateral sclerosis. The present invention relates to t...
2009 Invention Treatment of amyotrophic lateral sclerosis. The present invention relates to the identification o...
2002 Invention Screens and assays for agents useful in controlling parasitic nematodes. C. elegans secretory pat...
2001 Invention Insect control agent. The invention includes an expression vector engineered to produce double-st...